Naima Thavory Joseph, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 7 | 2023 | 2026 | 1.950 |
Why?
|
Stillbirth | 1 | 2023 | 346 | 0.710 |
Why?
|
Homicide | 1 | 2022 | 287 | 0.700 |
Why?
|
Reproductive Medicine | 1 | 2021 | 108 | 0.680 |
Why?
|
Maternal-Fetal Exchange | 1 | 2021 | 456 | 0.680 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 221 | 0.660 |
Why?
|
Pregnancy | 26 | 2023 | 29144 | 0.640 |
Why?
|
Antibody Formation | 2 | 2023 | 1402 | 0.600 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2020 | 378 | 0.570 |
Why?
|
Virus Diseases | 1 | 2023 | 711 | 0.570 |
Why?
|
Maternal Health Services | 1 | 2020 | 455 | 0.500 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1320 | 0.460 |
Why?
|
Hydatidiform Mole | 4 | 2016 | 279 | 0.440 |
Why?
|
Suicide | 1 | 2022 | 1477 | 0.410 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2021 | 2020 | 0.390 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2021 | 489 | 0.390 |
Why?
|
Georgia | 5 | 2022 | 186 | 0.380 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2015 | 484 | 0.380 |
Why?
|
Influenza, Human | 1 | 2022 | 1479 | 0.370 |
Why?
|
Papillomavirus Infections | 2 | 2021 | 1587 | 0.360 |
Why?
|
Pregnancy Outcome | 3 | 2022 | 2795 | 0.290 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7785 | 0.290 |
Why?
|
HIV-1 | 1 | 2022 | 6939 | 0.250 |
Why?
|
Perinatology | 1 | 2023 | 57 | 0.230 |
Why?
|
Female | 31 | 2023 | 380194 | 0.230 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
Pre-Eclampsia | 2 | 2021 | 1200 | 0.210 |
Why?
|
Uterine Neoplasms | 3 | 2016 | 1513 | 0.200 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 128 | 0.190 |
Why?
|
Pandemics | 5 | 2022 | 8388 | 0.170 |
Why?
|
Malawi | 1 | 2020 | 282 | 0.170 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 329 | 0.170 |
Why?
|
Infant, Newborn | 4 | 2023 | 25625 | 0.170 |
Why?
|
Parturition | 1 | 2023 | 441 | 0.170 |
Why?
|
International Classification of Diseases | 2 | 2021 | 867 | 0.160 |
Why?
|
Maternal Age | 3 | 2016 | 802 | 0.160 |
Why?
|
Prenatal Care | 2 | 2023 | 1092 | 0.160 |
Why?
|
Humans | 33 | 2023 | 744343 | 0.160 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4838 | 0.160 |
Why?
|
Adenine | 1 | 2022 | 936 | 0.150 |
Why?
|
Uganda | 1 | 2021 | 1243 | 0.150 |
Why?
|
Social Justice | 1 | 2021 | 456 | 0.140 |
Why?
|
Violence | 1 | 2022 | 909 | 0.140 |
Why?
|
HIV Infections | 1 | 2022 | 16718 | 0.140 |
Why?
|
Urban Population | 2 | 2020 | 2021 | 0.130 |
Why?
|
Papillomaviridae | 1 | 2021 | 1119 | 0.130 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 1978 | 0.130 |
Why?
|
Telemedicine | 2 | 2022 | 2872 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11524 | 0.120 |
Why?
|
Outpatients | 1 | 2022 | 1486 | 0.120 |
Why?
|
Quality of Health Care | 2 | 2020 | 4371 | 0.120 |
Why?
|
Antiviral Agents | 2 | 2023 | 2987 | 0.120 |
Why?
|
Organoplatinum Compounds | 1 | 2015 | 408 | 0.110 |
Why?
|
Vaccination | 2 | 2023 | 3278 | 0.110 |
Why?
|
Anti-Retroviral Agents | 1 | 2022 | 1715 | 0.110 |
Why?
|
Health Services Research | 1 | 2020 | 1836 | 0.110 |
Why?
|
Cesarean Section | 1 | 2020 | 1365 | 0.100 |
Why?
|
Cause of Death | 1 | 2022 | 3584 | 0.100 |
Why?
|
Population Surveillance | 1 | 2022 | 2616 | 0.100 |
Why?
|
Young Adult | 9 | 2021 | 56430 | 0.100 |
Why?
|
Diabetes, Gestational | 1 | 2021 | 1184 | 0.100 |
Why?
|
Cohort Studies | 4 | 2021 | 40561 | 0.100 |
Why?
|
Hospitals, Public | 2 | 2022 | 207 | 0.090 |
Why?
|
Neutropenia | 1 | 2015 | 895 | 0.090 |
Why?
|
Health Status Disparities | 1 | 2021 | 1797 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2022 | 77449 | 0.080 |
Why?
|
Prospective Studies | 3 | 2023 | 53288 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3086 | 0.080 |
Why?
|
Mortality | 1 | 2018 | 2864 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4933 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3479 | 0.070 |
Why?
|
Vaginal Smears | 1 | 2009 | 511 | 0.070 |
Why?
|
Infant | 3 | 2023 | 35136 | 0.070 |
Why?
|
Communication Barriers | 1 | 2009 | 398 | 0.070 |
Why?
|
Anemia | 1 | 2015 | 1506 | 0.070 |
Why?
|
Adult | 11 | 2021 | 214055 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 12720 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6895 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.060 |
Why?
|
Attitude to Health | 2 | 2009 | 2052 | 0.050 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2022 | 27 | 0.050 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 165 | 0.050 |
Why?
|
Papillomavirus Vaccines | 1 | 2009 | 491 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39050 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 25043 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2023 | 3176 | 0.050 |
Why?
|
Reproductive Rights | 1 | 2021 | 35 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12788 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12354 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5319 | 0.050 |
Why?
|
United States | 4 | 2022 | 69872 | 0.040 |
Why?
|
Medically Underserved Area | 1 | 2020 | 253 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18370 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2022 | 643 | 0.040 |
Why?
|
Demography | 1 | 2021 | 1656 | 0.040 |
Why?
|
Gravidity | 1 | 2016 | 51 | 0.040 |
Why?
|
Medical Records | 1 | 2021 | 1413 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1236 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3022 | 0.030 |
Why?
|
Postpartum Period | 1 | 2021 | 1086 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2460 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1698 | 0.030 |
Why?
|
Mass Screening | 1 | 2009 | 5255 | 0.030 |
Why?
|
New England | 1 | 2016 | 1022 | 0.030 |
Why?
|
Parity | 1 | 2016 | 929 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2902 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2015 | 57776 | 0.030 |
Why?
|
Chorionic Gonadotropin | 1 | 2014 | 477 | 0.030 |
Why?
|
Alleles | 1 | 2022 | 6933 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4560 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13102 | 0.020 |
Why?
|
Aged | 3 | 2018 | 163280 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 13033 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3952 | 0.020 |
Why?
|
Adolescent | 4 | 2018 | 85781 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9274 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8554 | 0.020 |
Why?
|
Culture | 1 | 2009 | 633 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 20947 | 0.020 |
Why?
|
Child | 2 | 2023 | 77709 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10262 | 0.010 |
Why?
|
Risk Factors | 3 | 2016 | 72290 | 0.010 |
Why?
|
Language | 1 | 2009 | 1471 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3341 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11031 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 41006 | 0.010 |
Why?
|
Middle Aged | 3 | 2018 | 213383 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2009 | 3158 | 0.010 |
Why?
|
Prognosis | 1 | 2014 | 29063 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2009 | 5137 | 0.010 |
Why?
|
Animals | 1 | 2014 | 168757 | 0.000 |
Why?
|
Male | 1 | 2018 | 350118 | 0.000 |
Why?
|